Metronidazole is considered to be a cost-effective drug because of its low cost, good activity against pathogenic
anaerobic bacteria, favorable pharmacokinetic and pharmacodynamic properties, and minor adverse effects.
Metronidazole is still the criterion standard for therapy of anaerobic infections,